The aim of our study was to assess the level of anti-UCH-L1 antibodies and anti-CD40 antibodies as potential factors of podocyte damage in patients with different glomerulopathies, and to evaluate their significance in diagnosis of primary podocyte diseases. Here, UCHL1 is linked to glomerular disorder.